What is low threshold methadone maintenance treatment?

International Journal of Drug Policy

Volumn 24, Issue 6, 2013, Pages

  Strike, Carol ^a   Millson, Margaret ^a   Hopkins, Shaun ^b   Smith, Christopher ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b The Works   (Canada)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

Canada; Harm reduction; Low threshold; Methadone maintenance; Program policies

Indexed keywords

METHADONE; OPIATE DERIVATIVE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CANADA; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG DEPENDENCE TREATMENT; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HELP SEEKING BEHAVIOR; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; MAINTENANCE THERAPY; MEDICAL PRACTICE; MEDICAL STAFF; METHADONE MAINTENANCE TREATMENT; MULTIPLE DRUG ABUSE; OPIATE ADDICTION; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RISK BENEFIT ANALYSIS; SEMI STRUCTURED INTERVIEW; THEMATIC ANALYSIS; TREATMENT OUTCOME; URINALYSIS; WITHDRAWAL SYNDROME; ADDICTION; ATTITUDE TO HEALTH; DRUG USE; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HEROIN DEPENDENCE; INTERVIEW; MEDICATION COMPLIANCE; OPIATE SUBSTITUTION TREATMENT; PROCEDURES; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PSYCHOLOGY;

ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; BEHAVIOR, ADDICTIVE; CANADA; DRUG USERS; HARM REDUCTION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEROIN DEPENDENCE; HUMANS; INTERVIEWS AS TOPIC; MEDICATION ADHERENCE; METHADONE; OPIATE SUBSTITUTION TREATMENT; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; SUBSTANCE ABUSE TREATMENT CENTERS; TREATMENT OUTCOME;

EID: 84890425161     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2013.05.005     Document Type: Article

References (31)

1. Ball J.C., Ross A. The effectiveness of methadone maintenance treatment 1991, Springer-Verlag, New York.
2. Bradby H. Medicine, health and society 2012, Sage Publications Ltd., London, England.
3. Buning E.C., Van Brussel G.H., Van Santen G. The 'methadone by bus' project in Amsterdam. British Journal of Addiction 1990, 85(10):1247-1250.
4. College of Physicians and Surgeons of Ontario Methadone maintenance guidelines 2005, College of Physicians and Surgeons of Ontario, Toronto.
5. Corbin J., Strauss A. Basics of qualitative research: Techniques and procedures for developing grounded theory 2008, Sage Publications Inc., Thousand Oaks, CA. 3rd ed.
6. Cushman P. Abstinence following detoxification and methadone maintenance treatment. American Journal of Medicine 1978, 65(1):46-52.
7. Dole V.P., Nywsander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. The Journal of the American Medical Association 1965, 23(193):646-650.
8. Finch E., Groves I., Feinman C., Farmer R. A low threshold stabilisation programme description and first stage evaluation. Addiction Research 1995, 3(1):63-71.
9. Gunne L., Gronbladh L. The Swedish methadone maintenance program. The social and medical aspects of drug-abuse 1984, 205-213. Spectrum Publications, New York. G. Serban (Ed.).
10. Hernandez S.H., Nelson L.S. Prescription drug abuse: Insight into the epidemic. Clinical Pharmacology & Therapeutics 2010, 88(3):307-317.
11. Klingemann H.K.H. Drug treatment in Switzerland: Harm reduction, decentralization and community response. Addiction 1996, 91:723-736.
12. Langendam M.W., van Brussel G.H., Coutinho R.A., van Ameijden E.J. The impact of harm-reduction-based methadone treatment on mortality among heroin users. American Journal of Public Health 2001, 91(5):774-780.
13. Lofland J., Snow D., Anderson L., Lofland L. Analyzing social settings: A guide to qualitative observation and analysis 2006, Wadworth Cengage Learning, Belmont, CA. 4th ed.
14. Magura S., Nwakeze P.C., Demsky S.Y. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998, 93(1):51-60.
15. Manchikanti L., Singh A. Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008, 11(2 (Suppl.)):S63-S88.
16. Mathers B.M., Degenhardt L., Ali H., Wiessing L., Hickman M., Mattick R.P., et al. HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. Lancet 2010, March, 375(9719):1014-1028. (Epub 2010 February 26). 10.1016/S0140-6736(10)60232-2.
17. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2009, July, (3). CD002209. 10.1002/14651858.CD002209.pub2.
18. McGlothlin W.H., Anglin M.D. Shutting off methadone. Costs and benefits. Archives of General Psychiatry 1981, 38(8):885-892.
19. Millson P., Challacombe L., Villeneuve P.J., Strike C.J., Fischer B., Myers T., et al. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Education and Prevention 2007, 19(2):124-136.
20. Rosenbaum M.I.J., Murphy S. De facto destabilization as policy. The impact of short-term methadone maintenance. Contemporary Drug Problems 1998, 15:497-517.
21. Ryrie I.W., Dickson J., Robbins C., Maclean K., Climpson C. Evaluation of a low-threshold clinic for opiate-dependent drug users. Journal of Psychiatric Mental Health Nursing 1997, 4(2):105-110.
22. Shield K.D., Ialomiteanu A., Fischer B., Mann R.E., Rehm J. Non-medical use of prescription opioids among Ontario adults: Data from the 2008/2009 CAMH Monitor. Canadian Journal of Public Health 2011, 102(5):330-335.
23. Simpson D.D., Joe G.W., Brown B.S. Treatment retention and followup outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviours 1997, 11(4):294-307.
24. Strain E.C., Bigelow G.E., Liebson I.A., Stitzer M.L. Moderate- vs high-dose methadone in the treatment of opioid dependence: A randomized trial. The Journal of the American Medical Association 1999, 281(11):1000-1005.
25. Strike C., Urbanoski K., Fischer B., Marsh D., Millson M. Policy changes and the methadone treatment system for opioid dependence in Ontario, 1996 to 2001. Journal of Addictive Diseases 2005, 24(1):39-52.
26. Strike C., Wenghofer E., Gnam W., Hillier W., Veldhuizen S., Millson M. Physician peer assessments for compliance with methadone maintenance treatment guidelines. Journal of Continuing Education in the Health Professions 2007, 27(4):208-213.
27. Torrens M., Castillo C., Pérez-Solá V. Retention in a low-threshold methadone maintenance program. Drug and Alcohol Dependence 1996, 41(1):55-59.
28. van Ameijden E.J., Langendam M.W., Coutinho R.A. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addictive Behaviours 1999, 24(4):559-563.
29. Ward J., Mattick R., Hall W. How long is long enough? Answers to questions about the duration of methadone maintenance treatment. Methadone maintenance treatment and other opioid replacement therapies 1998, 305-336. Harwood Academic Publishers, Amsterdam. J. Ward, R.P. Mattick, W. Hall (Eds.).
30. Yancovitz S.R., Des Jarlais D.C., Peyser N.P., Drewm E., Friedmann P., Trigg H.L., et al. A randomized trial of an interim methadone maintenance clinic. American Journal of Public Health 1991, 81(9):1185-1191.
31. Zhang Z., Friedmann P.D., Gerstein D.R. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003, 98(5):673-684.